Recent developments in tubulin polymerization inhibitors: An overview

被引:296
作者
Kaur, Ramandeep [1 ]
Kaur, Gurneet [1 ]
Gill, Rupinder Kaur [1 ,2 ]
Soni, Richard [1 ]
Bariwal, Jitender [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut Chem, Moga 142001, Punjab, India
[2] Punjab Tech Univ, Kapurthala 144601, Punjab, India
关键词
Tubulin polymerization; Tubulin polymerization inhibitors; Microtubules; Disruption of microtubules; VASCULAR-TARGETING AGENT; COLCHICINE-BINDING-SITE; BIOLOGICAL EVALUATION; COMBRETASTATIN A-4; ISOCOMBRETASTATIN A-4; BENZOSUBERENE ANALOGS; MICROTUBULE DYNAMICS; ANTIMITOTIC AGENTS; ANTITUMOR-ACTIVITY; STRUCTURAL BASIS;
D O I
10.1016/j.ejmech.2014.09.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Microtubules are protein biopolymers formed through polymerization of heterodimers of alpha- and beta-tubulins. Disruption of microtubules can induce cell cycle arrest in G(2)-M phase and formation of abnormal mitotic spindles. Their importance in mitosis and cell division makes microtubules an attractive target for anticancer drug discovery. A number of naturally occurring compounds such as paclitaxel, epothilones, vinblastine, combretastatin, and colchicines exert their effect by changing dynamics of tubulin such as polymerization and depolymerization. During past few years, rapid development of the novel tubulin polymerization inhibitors has been witnessed. Diverse classes of chemical compounds from the natural as well as from the synthetic origin have been extensively studied. This review highlights the various classes of synthetically derived chemical compounds those have been reported in last few years as potential tubulin polymerization inhibitors. A brief synthetic methodology to access these compounds has been highlighted along with the brief SAR studies. We strongly believe that this review will provide a platform to the synthetic chemists and biologists to design and synthesize new and potent compounds to inhibit the tubulin polymerization. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:89 / 124
页数:36
相关论文
共 129 条
[1]   Tracking the ends: a dynamic protein network controls the fate of microtubule tips [J].
Akhmanova, Anna ;
Steinmetz, Michel O. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (04) :309-322
[2]   Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1 [J].
Akselsen, Oyvind W. ;
Odlo, Kristin ;
Cheng, Jing-Jy ;
Maccari, Giorgio ;
Botta, Maurizio ;
Hansen, Trond Vidar .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (01) :234-242
[3]  
Al-awar RS, 2004, MOL CANCER THER, V3, P1061
[4]   Endowing Indole-Based Tubulin Inhibitors with an Anchor for Derivatization: Highly Potent 3-Substituted Indolephenstatins and Indoleisocombretastatins [J].
Alvarez, Raquel ;
Puebla, Pilar ;
Fernando Diaz, J. ;
Bento, Ana C. ;
Garcia-Navas, Rosula ;
de la Iglesia-Vicente, Janis ;
Mollinedo, Faustino ;
Manuel Andreu, Jose ;
Medarde, Manuel ;
Pelaez, Rafael .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (07) :2813-2827
[5]   What tubulin drugs tell us about microtubule structure and dynamics [J].
Amos, Linda A. .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2011, 22 (09) :916-926
[6]   Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle [J].
Andreani, A ;
Granaiola, M ;
Leoni, A ;
Locatelli, A ;
Morigi, R ;
Rambaldi, M ;
Garaliene, V ;
Welsh, W ;
Arora, S ;
Farruggia, G ;
Masotti, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (17) :5604-5607
[7]   Substituted 3-(5-Imidazo[2,1-b]thiazolylmethylene)-2-indolinones and Analogues: Synthesis, Cytotoxic Activity, and Study of the Mechanism of Action [J].
Andreani, Aldo ;
Granaiola, Massimiliano ;
Locatelli, Alessandra ;
Morigi, Rita ;
Rambaldi, Mirella ;
Varoli, Lucilla ;
Calonghi, Natalia ;
Cappadone, Concettina ;
Farruggia, Giovanna ;
Stefanelli, Claudio ;
Masotti, Lanfranco ;
Nguyen, Tam L. ;
Hamel, Ernest ;
Shoemaker, Robert H. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (05) :2078-2088
[8]   Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and t-cell lymphoma [J].
Aneja, Ritu ;
Vangapandu, Surya N. ;
Lopus, Manu ;
Chandra, Ramesh ;
Panda, Dulal ;
Joshi, Harish C. .
MOLECULAR PHARMACOLOGY, 2006, 69 (06) :1801-1809
[9]   Effects of rhizoxin, a microbial angiogenesis inhibitor, on angiogenic endothelial cell functions [J].
Aoki, K ;
Watanabe, K ;
Sato, M ;
Ikekita, M ;
Hakamatsuka, T ;
Oikawa, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 459 (2-3) :131-138
[10]   INHIBITION OF GROWTH OF COLON-38 ADENOCARCINOMA BY VINBLASTINE AND COLCHICINE - EVIDENCE FOR A VASCULAR MECHANISM [J].
BAGULEY, BC ;
HOLDAWAY, KM ;
THOMSEN, LL ;
ZHUANG, L ;
ZWI, LJ .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (04) :482-487